Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Diagnostics
Markers distinguish primary ovarian tumors from metastatic colorectal cancer
March 17th, 2005
Three immunohistochemical markers expressed in colonic adenocarcinoma help differentiate ovarian tumors from metastatic colorectal cancer, Emory University Hospital pathologists report. "Distinguishing primary ovarian carcinoma, particularly endometrioid and mucinous subtypes, from metastatic colorectal carcinoma to the ovary is often difficult on histologic examination alone. Recently, three immunohistochemical markers - CDX2, a homeobox gene encoding an intestine-specific transcription factor; alpha-methylacyl-CoA racemase (AMACR/P504S), a mitochondrial and peroxisomal enzyme with fairly restricted expression in selective tumors; and beta-catenin, an adenomatous...
Source: Women's Health Weekly (2005-03-17)
|
